American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control*

This publication has 43 references indexed in Scilit:

• UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis
  Diabetologia, 2001
• How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
  Diabetes Care, 1999
• Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals
  Atherosclerosis, 1999
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
  The Lancet, 1998
• Is there an ethnic difference in the effect of risk factors for diabetic retinopathy?
  Annals of Epidemiology, 1993
• Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis
  Diabetes Care, 1992
• Metabolic control and complications over 3 years in patients with insulin dependent diabetes (IDDM): the Stockholm Diabetes Intervention Study (SDIS)
  Journal of Internal Medicine, 1990
• Disparities in Incidence of Diabetic End-Stage Renal Disease According to Race and Type of Diabetes
  New England Journal of Medicine, 1989
• Abnormal Patterns of Insulin Secretion in Non-Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1988